JAMIE NIEHAUS: Open Payments
NPI 1629611843 · LEITCHFIELD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$953 in 57 payments from 16 companies in 2025. Trend: 2023 $1,241 · 2024 $727 · 2025 $953
Food & beverage: $953
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $370 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $146 |
| Phathom Pharmaceuticals, Inc. | 5 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Lilly USA, LLC | 2 | $38 |
| Amgen Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Ardelyx, Inc. | 2 | $33 |
| Verona Pharma, Inc. | 2 | $30 |
| Exact Sciences Corporation | 2 | $29 |
Products named: CAPLYTA, Ozempic, Wegovy, Rybelsus, VOQUEZNA, AIRSUPRA, MOUNJARO, Auvelity.
Industry payments across KY — which companies pay providers there.
